Viewing Study NCT07037420

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2025-12-26 @ 3:04 AM
Study NCT ID: NCT07037420
Status: RECRUITING
Last Update Posted: 2025-12-12
First Post: 2025-05-27
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly
Sponsor: Alexion Pharmaceuticals, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acromegaly View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Acromegaly View
None ALXN2420 View
None Somatostatin Analog View
None insulin-like growth factor 1 View
None IGF-1 View
None SSA therapy View
None GHRA View
None Growth Hormone Receptor Antagonist View